<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JAMA Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">JAMA Neurol</journal-id>
<journal-id journal-id-type="pmc">JAMA Neurol</journal-id>
<journal-title-group>
<journal-title>JAMA Neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">2168-6149</issn>
<issn pub-type="epub">2168-6157</issn>
<publisher>
<publisher-name>American Medical Association</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29913018</article-id>
<article-id pub-id-type="pmc">6233854</article-id>
<article-id pub-id-type="doi">10.1001/jamaneurol.2018.1478</article-id>
<article-id pub-id-type="publisher-id">noi180036</article-id>
<article-categories>
<subj-group specific-use="electronic" subj-group-type="category">
<subject>Research</subject>
</subj-group>
<subj-group specific-use="print" subj-group-type="domain">
<subject>Research</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Investigation</subject>
</subj-group>
<subj-group specific-use="electronic" subj-group-type="featured">
<subject>Featured</subject>
</subj-group>
<subj-group subj-group-type="online-first">
<subject>Online First</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders</article-title>
<alt-title alt-title-type="headline">Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders</alt-title>
<alt-title alt-title-type="running-head">Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Montaut</surname>
<given-names>Solveig</given-names>
</name>
<degrees>MD</degrees>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="noi180036aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tranchant</surname>
<given-names>Christine</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="noi180036aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="noi180036aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="noi180036aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Drouot</surname>
<given-names>Nathalie</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="noi180036aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rudolf</surname>
<given-names>Gabrielle</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="noi180036aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="noi180036aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="noi180036aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guissart</surname>
<given-names>Claire</given-names>
</name>
<degrees>PharmD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="noi180036aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tarabeux</surname>
<given-names>Julien</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="noi180036aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stemmelen</surname>
<given-names>Tristan</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="noi180036aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Velt</surname>
<given-names>Amandine</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="noi180036aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fourrage</surname>
<given-names>Cécile</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="noi180036aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nitschké</surname>
<given-names>Patrick</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="noi180036aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gerard</surname>
<given-names>Bénédicte</given-names>
</name>
<degrees>PharmD</degrees>
<degrees>PhD</degrees>
<degrees>GC</degrees>
<xref ref-type="aff" rid="noi180036aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mandel</surname>
<given-names>Jean-Louis</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="noi180036aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="noi180036aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koenig</surname>
<given-names>Michel</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="noi180036aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chelly</surname>
<given-names>Jamel</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="noi180036aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="noi180036aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="noi180036aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Anheim</surname>
<given-names>Mathieu</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="noi180036aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="noi180036aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="noi180036aff3">
<sup>3</sup>
</xref>
</contrib>
<on-behalf-of>for the French Parkinson’s and Movement Disorders Consortium</on-behalf-of>
</contrib-group>
<aff id="noi180036aff1"><label>1</label>Département de Neurologie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France</aff>
<aff id="noi180036aff2"><label>2</label>Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France</aff>
<aff id="noi180036aff3"><label>3</label>Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France</aff>
<aff id="noi180036aff4"><label>4</label>EA7402, Laboratoire de Génétique Moléculaire, Institut de Recherche Clinique, Montpellier University Hospital, France</aff>
<aff id="noi180036aff5"><label>5</label>Laboratoire de Diagnostic Génétique, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France</aff>
<aff id="noi180036aff6"><label>6</label>Institut Imagine, Imagine Bioinformatics Platform, Paris Descartes University, Paris, France</aff>
<author-notes>
<title>Article Information</title>
<p content-type="byline-footnote" specific-use="print"><bold>Group Information:</bold> The French Parkinson’s and Movement Disorders Consortium members are listed at the end of this article.</p>
<corresp id="noi180036cor1"><bold>Corresponding Author:</bold> Mathieu Anheim, MD, PhD, Département de Neurologie, Hôpital de Hautepierre, 1 Ave Molière, 67098 Strasbourg Cedex, France (<email xlink:href="mathieu.anheim@chru-strasbourg.fr">mathieu.anheim@chru-strasbourg.fr</email>).</corresp>
<p><bold>Accepted for Publication:</bold> March 8, 2018.</p>
<p content-type="published-online"><bold>Published Online:</bold> June 18, 2018. doi:<uri content-type="doi">10.1001/jamaneurol.2018.1478</uri></p>
<p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Anheim and Chelly had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Montaut and Tranchant equally contributed to the work and should be considered co-first authors. Drs Chelly and Anheim equally contributed to the work and should be considered co-last authors.</p>
<p><italic>Study concept and design: </italic>Montaut, Tranchant, Drouot, Mandel, Chelly, Anheim.</p>
<p><italic>Acquisition, analysis, or interpretation of data: </italic>Montaut, Tranchant, Drouot, Rudolf, Guissart, Tarabeux, Stemmelen, Velt, Fourrage, Nitschké, Gérard, Koenig, Chelly, Anheim.</p>
<p><italic>Drafting of the manuscript: </italic>Montaut, Rudolf, Tarabeux, Fourrage, Chelly, Anheim.</p>
<p><italic>Critical revision of the manuscript for important intellectual content: </italic>Tranchant, Drouot, Guissart, Stemmelen, Velt, Nitschké, Gérard, Mandel, Koenig, Chelly, Anheim.</p>
<p><italic>Statistical analysis: </italic>Montaut.</p>
<p><italic>Obtained funding: </italic>Mandel, Chelly, Anheim.</p>
<p><italic>Administrative, technical, or material support: </italic>Montaut, Drouot, Rudolf, Tarabeux, Gérard, Chelly, Anheim.</p>
<p><italic>Study supervision: </italic>Montaut, Tranchant, Chelly, Anheim.</p>
<p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> None reported.</p>
<p content-type="funding-statement"><bold>Funding/Support: </bold>The study has been supported by a grant from France Parkinson.</p>
<p><bold>Role of the Funder/Sponsor:</bold> The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
<p content-type="study-group-members-end"><bold>The French Parkinson’s and Movement Disorders (PMD) Consortium: </bold>Département de Neuropédiatrie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France: Marie-Thérèse Abi-Warde, MD; Anne De Saint Martin, MD. Département de Neurologie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France: Charles Behr, MD, PhD; Ouhaid Lagha Boukbiza, MD. Département de Neurologie, Centre Hospitalier Universitaire de Marseille, Hôpital de la Timone, Marseille, France: Jean-Philippe Azulay, MD, PhD; Emmanuelle Boutin, MD; Alexandre Eusebio, MD, PhD; Frédérique Fluchere, MD; Elsa Kaphan, MD. Département de Neurologie, Centre Hospitalier Universitaire Henri Mondor, Créteil, France: Anne Catherine Bachoud Levi, MD, PhD; Gilles Fenelon, MD, PhD; Jean-Marie Gurruchaga, MD. Service de Neurologie, Hôpital de Mercy, Centre Hospitalier de Metz-Thionville, Metz, France: Carmen Badiu, MD. Service de Neurologie, Centre Hospitalier de la Côte Basque, Bayonne, France: Charles Behr, MD. Département de Neurologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France: Matthieu Bereau, MD; Ludivine Chamard, MD. Département de Neurologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France: Christine Brefel-Courbon, MD, PhD; Jonathan Curot, MD; Julia Dupouy, MD. Département de Neurologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France: Pierre Burbaud, MD, PhD; Virginie Chrystostome, MD; Antoine Gradel, MD. Département de Neurologie, Centre Hospitalier Universitaire de Grenoble, France: Anna Castrioto, MD, PhD. Département de Neurochirurgie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France: Ana Laura Cif, France, MD, PhD; Victoria Gonzales, MD. Département de Neurologie, Centre Hospitalier Universitaire Paris–GH La Pitié Salpêtrière–Charles Foix–Hôpital Pitié-Salpêtrière, Assistance Publique–Hôpitaux de Paris, Paris, France: Maria Clara Coelho Braga, MD; Pauline Dodet, MD; Bertrand Degos, MD, PhD; Emmanuel Flamand-Roze, MD, PhD; David Grabli, MD, PhD; Andreas Hartmann, MD, PhD. Département de Neurologie, Centre Hospitalier Universitaire de Nantes, Nantes, France: Philippe Damier, MD, PhD, MBA; Pascal Derkinderen, MD, PhD. Département de Neurologie, Centre hospitalier universitaire de Reims, Reims, France: Anne Doe De Maindreville, MD. Département de Neuropédiatrie, Centre Hospitalier Universitaire Paris Est–Hôpital d'Enfants Armand-Trousseau, Assistance Publique–Hôpitaux de Paris, Paris, France: Diane Doummar, MD, PhD. Département de Neurologie, Centre Hospitalier Universitaire de Rennes, Rennes, France: Sophie Drapier, MD. Service de Génétique Clinique, Pôle de Pédiatrie Médico-Chirurgicale Et Génétique Clinique, Centre Hospitalier Universitaire de Rennes–Hôpital Sud, Rennes, France: Mélanie Fradin, MD. Département de Neurologie, Centre Hospitalier Universitaire de Nancy, Nancy, France: Solène Frismand, MD. Service de Neurologie, Centre Hospitalier Universitaire Gabriel-Montpied, Clermont-Ferrand, France: François Gampourou, MD. Département de Neuropédiatrie, Hôpital Universitaire Robert Debré, Assistance Publique–Hôpitaux de Paris, Paris: Domitille Gras, MD. Service de Génétique/Unité de Génétique Clinique, Centre Hospitalier Universitaire de Rouen–Hôpital Charles Nicolle, Rouen, France: Lucie Guyant-Marechal, MD. Fondation Ophtalmologique Adolphe de Rothschild, Paris, France: Cécile Hubsch, MD, PhD. Neuropédiatrie, Hôpital Pellegrin-Enfants, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France: Marie Husson, MD. Département de Neurologie, Centre Hospitalier de Luxembourg, Luxembourg: Rejko Krüger, MD. Service de Neurologie, Centre Hospitalier Universitaire Amiens-Picardie–Site Sud, Amiens, France: Pierre Krystkowiak, MD, PhD. Département de Neurologie, Hôpital Pierre Wertheimer, Hôpitaux Civils de Lyon, Lyon, France: Chloé Laurencin, MD. Département de Neurologie, CHU de Bordeaux, Bordeaux, France: Brice Laurens, MD. Département de Neurologie, CHU de Rouen - Hôpital Charles Nicolle, Rouen, France: Romain Lefaucheur, MD; Gaël Nicolas, MD, PhD; Marie-Laure Welter, MD, PhD. Service de Neurologie Pédiatrique, Hôpital Femme Mère Enfant, Hôpitaux Civils de Lyon, Lyon, France: Laurence Lion-Francois, MD. Département de Neurologie, Hôpital Nord - CHU Grenoble Alpes, Grenoble, France: Martial Mallaret, MD, PhD. Département de Neurologie, CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière, AP-HP, Paris, France: Louise-Laure Mariani, MD; Yann Nadjar, MD; Savine Vicart, MD; Marie Vidailhet, MD, PhD. Pôle des Neurosciences Cliniques, CHU de Bordeaux-GH Pellegrin, Bordeaux, France: Wassilios Meissner, MD, PhD. Service de génétique, CHU de Reims - Hôpital Maison Blanche, Reims, France: Monique Mozelle Nivoix, MD. Département de Neurologie, CHU de Toulouse, Toulouse, France: Fabienne Ory-Magne, MD; Olivier Rascol, MD, PhD. Centre Hospitalier Sud-Francilien, Corbeil-Essones, France: Ivania Patry, MD. Département de Neurologie, Hôpital Pierre Wertheimer, Hôpitaux Civils de Lyon, Lyon, France: Alice Poisson, MD, PhD. Département de Neurologie, CHU Henri Mondor, Créteil, France: Philippe Remy, MD, PhD; Hayet Salhi, MD. Département de Neurologie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France: Mathilde Renaud, MD, PhD. Département de Neurologie, CHU de Marseille - Hôpital de la Timone, Marseille, France: Wissam Rizk, MD; Tatiana Witjas, MD. Département de Neurologie, Hôpital G.R. Laennec, CHU de Nantes, Nantes, France: Tiphaine Rouaud, MD. Département de neuropédiatrie, Pôle Femme Mère Enfant, CHRU de Montpellier - Hôpital Gui de Chauliac, Montpellier, France: Agathe Roubertie, MD, PhD. Service de Neurologie, Hopital Zobda-Quitman, CHU de Fort-de-France, Martinique, France: Aissatou Signate, MD. Département de Neuropédiatrie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France: Marie-Aude Spitz, MD. Département de Neurologie, Centre hospitalier universitaire Le Kremlin Bicêtre, AP-HP, Paris, France: Maeva Stephant, MD. Service de Neurologie, CHU Amiens-Picardie - Site Sud, Amiens, France: Mélissa Tir, MD, PhD. Service de Neurologie, CHU de Bordeaux-GH Pellegrin, Bordeaux, France: François Tison, MD, PhD. Service de Neurologie, CHU Annaba, Annaba, Algeria: Nadia Toubal, MD. Service de Neurologie, CHU Gabriel-Montpied, Clermont-Ferrand, France: Miguel Ulla, MD, PhD. Département de Neurologie, CHU de Rennes, Rennes, France: Marc Verin, MD, PhD. Service de Neurologie, Centre Hospitalier de Verdun, Verdun, France: Jean-Médard Zola, MD.</p>
<p><bold>Additional Contributions:</bold> The authors thank the patients and their families for participation in this study, Bernard Jost, PhD, the IGBMC Microarray and Sequencing Platform; Cécilia Marelli, MD, PhD, the Department of Neurology of the University Hospital of Montpellier; Bernard Michel, MD, the Department of Neurology of the University Hospital of Marseille; Abderrahim M'zahem, MD, the University Hospital of Constantine; and Jean-François Deleuze, PhD, the Centre National de Génotypage (CNG) and the IdEx project for their support with design and conduct of the study. They received no compensation from a funding source for their contributions.</p>
</author-notes>
<pub-date iso-8601-date="2018-06-18T10:00" pub-type="epub">
<day>18</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>18</day>
<month>6</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>75</volume>
<issue>10</issue>
<fpage>1234</fpage>
<lpage>1245</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="final">
<day>23</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>3</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright 2018 American Medical Association. All Rights Reserved.</copyright-statement>
</permissions>
<self-uri content-type="pdf-version" xlink:href="jamaneurol-75-1234.pdf">jamaneurol-75-1234.pdf</self-uri>
<self-uri content-type="roundpoint" xlink:href="https://app.jamanetwork.com/?doi=10.1001/jamaneurol.2018.1478"></self-uri>
<self-uri content-type="silverchair" xlink:href="https://archneur.jamanetwork.com/article.aspx?doi=10.1001/jamaneurol.2018.1478"></self-uri>
<abstract abstract-type="key-points">
<title>Key Points</title>
<sec id="ab-noi180036-1">
<title>Question</title>
<p>Is a customized gene panel study suitable for the identification of genes associated with movement disorders?</p>
</sec>
<sec id="ab-noi180036-2">
<title>Findings</title>
<p>This study aimed at developing a targeted sequencing approach using a panel of 127 genes involved in movement disorders and evaluating its performance through analysis of a cohort of 378 patients. A diagnostic yield of 22% was achieved, highlighting some unexpected genotype-phenotype correlations and 49 novel pathogenic variants.</p>
</sec>
<sec id="ab-noi180036-3">
<title>Meaning</title>
<p>High-coverage sequencing panel to identify genes associated with movement disorders provided a useful and efficient diagnostic alternative to whole-exome and whole-genome sequencing.</p>
</sec>
</abstract>
<abstract abstract-type="teaser">
<p>This study aims to develop and evaluate a targeted sequencing approach using a customized panel of genes associated with movement disorders.</p>
</abstract>
<abstract>
<sec id="ab-noi180036-4">
<title>Importance</title>
<p>Movement disorders are characterized by a marked genotypic and phenotypic heterogeneity, complicating diagnostic work in clinical practice and molecular diagnosis.</p>
</sec>
<sec id="ab-noi180036-5">
<title>Objective</title>
<p>To develop and evaluate a targeted sequencing approach using a customized panel of genes involved in movement disorders.</p>
</sec>
<sec id="ab-noi180036-6">
<title>Design, Setting and Participants</title>
<p>We selected 127 genes associated with movement disorders to create a customized enrichment in solution capture array. Targeted high-coverage sequencing was applied to DNA samples taken from 378 eligible patients at 1 Luxembourgian, 1 Algerian, and 25 French tertiary movement disorder centers between September 2014 and July 2016. Patients were suspected of having inherited movement disorders because of early onset, family history, and/or complex phenotypes. They were divided in 5 main movement disorder groups: parkinsonism, dystonia, chorea, paroxysmal movement disorder, and myoclonus. To compare approaches, 23 additional patients suspected of having inherited cerebellar ataxia were included, on whom whole-exome sequencing (WES) was done. Data analysis occurred from November 2015 to October 2016.</p>
</sec>
<sec id="ab-noi180036-7">
<title>Main Outcomes and Measures</title>
<p>Percentages of individuals with positive diagnosis, variants of unknown significance, and negative cases; mutational frequencies and clinical phenotyping of genes associated with movement disorders.</p>
</sec>
<sec id="ab-noi180036-8">
<title>Results</title>
<p>Of the 378 patients (of whom 208 were male [55.0%]), and with a median (range) age at disease onset of 31 (0-84) years, probable pathogenic variants were identified in 83 cases (22.0%): 46 patients with parkinsonism (55% of 83 patients), 21 patients (25.3%) with dystonia, 7 patients (8.4%) with chorea, 7 patients (8.4%) with paroxysmal movement disorders, and 2 patients (2.4%) with myoclonus as the predominant phenotype<italic>.</italic> Some genes were mutated in several cases in the cohort. Patients with pathogenic variants were significantly younger (median age, 27 years; interquartile range [IQR], 5-36 years]) than the patients without diagnosis (median age, 35 years; IQR, 15-46 years; <italic>P</italic> = .04). Diagnostic yield was significantly lower in patients with dystonia (21 of 135; 15.6%; <italic>P</italic> = .03) than in the overall cohort. Unexpected genotype-phenotype correlations in patients with pathogenic variants deviating from the classic phenotype were highlighted, and 49 novel probable pathogenic variants were identified. The WES analysis of the cohort of 23 patients with cerebellar ataxia led to an overall diagnostic yield of 26%, similar to panel analysis but at a cost 6 to 7 times greater.</p>
</sec>
<sec id="ab-noi180036-9">
<title>Conclusions and Relevance</title>
<p>High-coverage sequencing panel for the delineation of genes associated with movement disorders was efficient and provided a cost-effective diagnostic alternative to whole-exome and whole-genome sequencing.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>